Nichols William Garrett - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 28, 2025, Nichols William Garrett's relationship to Candel Therapeutics, Inc. (CADL) is Officer (Chief Medical Officer), and currently has 53,430 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CADL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Nichols William Garrett - Insider Non-Derivative Transactions of CADL Common Stock

Nichols William Garrett - Insider Non-Derivative Transactions at CADL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 29, 2025	Sell -- (Common Stock)	937	6.98	52493
Jul 29, 2025	M -- (Common Stock)	937	1.29	53430
Jul 1, 2025	Sell -- (Common Stock)	781	5.04	52493
Jul 1, 2025	M -- (Common Stock)	781	1.29	53274
Mar 19, 2025	Sell -- (Common Stock)	45316	8.76	52493
Mar 19, 2025	M -- (Common Stock)	4584	3.75	83904
Mar 19, 2025	M -- (Common Stock)	13905	1.29	97809
Jan 16, 2025	Sell -- (Common Stock)	10428	7.23	79320
Jan 9, 2025	Sell -- (Common Stock)	10799	8.22	89748
Nov 30, 2024	Sell -- (Common Stock)	13935	4.56	100547
Jul 18, 2024	Sell -- (Common Stock)	10875	6.47	114482
Jul 12, 2024	Sell -- (Common Stock)	9769	5.97	125357
Nov 29, 2023	F -- (Common Stock)	12175	0.9	135126
Nov 27, 2023	Acquisition -- (Common Stock)	88822	0	147301